Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Create alerts with multiple filters including highs/low, comparative values, and turning points. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Pfenex Inc (PFNX)

Pfenex Inc (PFNX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 437,287
  • Shares Outstanding, K 34,297
  • Annual Sales, $ 50,330 K
  • Annual Income, $ 1,060 K
  • 60-Month Beta 1.32
  • Price/Sales 8.70
  • Price/Cash Flow 140.87
  • Price/Book 5.90
Trade PFNX with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.23
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/05/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.21
  • Number of Estimates 3
  • High Estimate -0.18
  • Low Estimate -0.22
  • Prior Year 0.09
  • Growth Rate Est. (year over year) -333.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.51 +1.92%
on 08/31/20
12.95 -1.54%
on 09/03/20
+0.20 (+1.59%)
since 08/28/20
3-Month
6.91 +84.52%
on 07/31/20
13.38 -4.71%
on 08/11/20
+4.40 (+52.69%)
since 06/30/20
52-Week
5.26 +142.40%
on 05/01/20
14.00 -8.93%
on 02/18/20
+4.31 (+51.07%)
since 09/30/19

Most Recent Stories

More News
Pipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for precision neuroregeneration, today announced the appointment of...

PFNX : 12.75 (-0.08%)
IBIO : 0.2795 (+5.63%)
TransCode Therapeutics Announces Key Appointments

TransCode Therapeutics today announced that it has recently elected a Chairman of its Board of Directors, appointed two new Independent Directors to the Board, and appointed a new member to its Advisory...

ARCT : 17.03 (-2.57%)
ANAB : 25.00 (+4.73%)
PFNX : 12.75 (-0.08%)
Ligand Announces Expiration of Tender Offer for Shares of Pfenex Inc.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Pfenex Inc. (NYSE American: PFNX) at...

LGND : 101.97 (-3.88%)
PFNX : 12.75 (-0.08%)
Lifshitz Law Firm, P.C. Announces Investigation of Pfenex Inc. (NYSE: PFNX), Proteostasis Therapeutics, Inc. (NASDAQ: PTI), Rosetta Stone Inc. (NYSE:RST) and Yintech Investment Holdings Limited (NASDAQ: YIN)

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) --

PFNX : 12.75 (-0.08%)
PTI : 1.1100 (-3.48%)
RST : 29.99 (unch)
YIN : 7.25 (+0.14%)
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - OTEL, ONDK, MXIM, PFNX

NEW YORK, NY / ACCESSWIRE / September 16, 2020 / Halper Sadeh LLP, a global investor rights law firm, is investigating: Otelco Inc. (NASDAQ:OTEL) concerning potential violations of the federal securities...

OTEL : 11.74 (+0.15%)
ONDK : 1.8300 (-3.17%)
MXIM : 103.14 (-1.18%)
PFNX : 12.75 (-0.08%)
ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – BLDR, CBMG, PFNX

NEW YORK, NY / ACCESSWIRE / September 12, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Builders FirstSource, Inc. (NASDAQ:BLDR) concerning potential violations...

BLDR : 70.26 (+2.76%)
CBMG : 19.75 (unch)
PFNX : 12.75 (-0.08%)
INVESTIGATION ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – MXIM, JCAP, GLIBA, PFNX

Halper Sadeh LLP, a global investor rights law firm, is investigating:

MXIM : 103.14 (-1.18%)
JCAP : 17.22 (-0.23%)
GLIBA : 91.73 (-2.57%)
PFNX : 12.75 (-0.08%)
Moore Kuehn Encourages SBPH, PFNX, VAR, and PRNB Investors to Contact Law Firm

NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether...

SBPH : 4.8400 (unch)
VAR : 177.07 (-0.02%)
PRNB : 100.05 (+0.10%)
PFNX : 12.75 (-0.08%)
ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm – DCOM, OTEL, PFNX, MR

ALERT: Halper Sadeh LLP Is Investigating the Following Mergers; Shareholders are Encouraged to Contact the Firm - DCOM, OTEL, PFNX, MR NEW YORK, NY / ACCESSWIRE / September 3, 2020 /Halper Sadeh LLP, a...

DCOM : 34.34 (+0.06%)
OTEL : 11.74 (+0.15%)
PFNX : 12.75 (-0.08%)
MR : 5.36 (-1.29%)
INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm – PRNB, BLDR, PFNX, MVC

NEW YORK, NY / ACCESSWIRE / September 1, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate: Principia Biopharma Inc. (NASDAQ:PRNB) concerning potential violations of...

PRNB : 100.05 (+0.10%)
BLDR : 70.26 (+2.76%)
PFNX : 12.75 (-0.08%)
MVC : 9.12 (+2.59%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Pfenex Inc. is a clinical-stage biotechnology company developing and commercializing proteins. The company's lead product candidate is PF582, a biosimilar candidate to Lucentis, for the potential treatment of patients with retinal diseases. It leverages its Pf'nex Expression Technology (TM) platform...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 13.01
1st Resistance Point 12.88
Last Price 12.75
1st Support Level 12.68
2nd Support Level 12.61
3rd Support Level N/A

See More

52-Week High 14.00
Last Price 12.75
Fibonacci 61.8% 10.66
Fibonacci 50% 9.63
Fibonacci 38.2% 8.60
52-Week Low 5.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar